NEW YORK, April 14 (Reuters) - Shares of Santarus Inc , a specialty pharmaceutical company, slumped 47.8 percent to $2.80 after the bell on Wednesday, following a judge's ruling on the company's patent lawsuit against Par Pharmaceutical Inc. For details, see
(Reporting by Ellis Mnyandu; Editing by Leslie Adler) Keywords: MARKETS STOCKS AFTERTHEBELL (Ellis.Mnyandu@thomsonreuters.com; +1 646 223 6085; Reuters Messaging:ellis.mnyandu.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
(Reporting by Ellis Mnyandu; Editing by Leslie Adler) Keywords: MARKETS STOCKS AFTERTHEBELL (Ellis.Mnyandu@thomsonreuters.com; +1 646 223 6085; Reuters Messaging:ellis.mnyandu.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.